Morris Matthew Shawn sold $3.8M of PRVA
Morris Matthew Shawn sold 151,322 shares of Privia Health Group, Inc. (PRVA) at $25.33 ($3.83M total) across 2 trades over 2026-06-26 to 2026-06-29 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The only new information is the disclosed sale size, price ($25.33), trade dates, and confirmation of a pre-arranged 10b5-1 plan.
Market read
Insider selling disclosure can influence short-term sentiment, but 10b5-1 status reduces interpretability as a negative fundamental signal.
What to watch
Traders may over-weight insider sales; without accompanying buys, guidance changes, or operational news, the signal is typically weak.
Background
The filing is an SEC Form 4 insider transaction for Privia Health Group, Inc., reported by a director.
Ticker impact
Privia Health Group director Morris Matthew Shawn sold 151,322 shares in open-market trades at $25.33 (10b5-1 plan disclosed).
Likely limited near-term impact; any reaction should be muted given 10b5-1 pre-arrangement.
Form 4 provides transaction size, price, and 10b5-1 status, but no new company performance, guidance, or deal information.
Market effects
No sector read-through; this is company-specific insider transaction disclosure.
No meaningful regional impact indicated.
No global market relevance indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations.
Key entities
- public_companyPrivia Health Group, Inc.
Issuer of the Form 4 insider sale; director sold 151,322 shares at $25.33.
- insiderMorris Matthew Shawn
Director who executed open-market sales under a Rule 10b5-1 plan.
